baber/WOPTO huggingface dataset:
Patent IE-41474-B1 (IE)
Title: -thiomethylergolines
IPC: A61P35/00
Filed: 1975-06-03
Abstract: 1505296 8-Thiomethylergoline derivatives ELI LILLY & CO 3 June 1975 [6 June 1974] 23869/75 Heading C2C Novel compounds of the Formula II wherein R is H, CN, COalk, phenyl or alk; R1 is H, Cl or Br; alk is C 1-3 alkyl and the dotted line is an optical bond and pharmaceuticallyacceptable acid addition salts thereof, may be prepared by reacting a compound of the Formula III wherein R 2 is methanesulphonyl or p-toluene sulphonyl with an alkali metal salt of a compound R35H, wherein R3 is CN, COalk, phenyl or alk, optionally followed where R3 is -COalk by hydrolysis to produce a compound II in which R is H. D - 6 - Methyl - 8 - mesyloxymethylergoline and its 9,10-didehydro derivative are prepared by reacting the corresponding 8-hydroxymethyl compound with methane sulphonyl chloride. Pharmaceutical compositions of the compounds II with the usual excipients are prolactin inhibitors when administered parenterally.
Patent IE-41153-B1 (IE)
Title: Improvements in or relating to sealing glands for cable lead-ins
IPC: H02G3/22
Filed: 1975-06-04
Abstract: 1506522 Cable glands SIEMENS AG 2 June 1975 [7 June 1974] 23801/75 Heading H2E A synthetic resin cable gland comprises one or more segments 8, 9, 10 each segment comprising a plurality of laminar sealing elements 2, held parallel and spaced apart by partitions 21, and means clamping together the segments. Fig. 2 shows the gland in the form of a blank having regions 12, 13, 14, 17, 18 which can be cut out as desired for the cable or cables to be supported by the gland; Fig. 3 shows region 12 cut out. In use, the segments are clamped about the cable or cables which have been coated in sealing compound (5), Fig. 1 (not shown), by, e.g., screws 11 in stiffening elements 11 within the spaces 3 between the sealing elements 2. The sealing elements extend around the extreme periphery of the gland and these may be sealed with compound (5<SP>1</SP>) and fitted into a clamp (6, 6<SP>1</SP>).
[GB1506522A]
Patent IE-56252-B1 (IE)
Title: Ecl circuit
IPC: H03K19/086
Filed: 1983-05-31
Abstract: An ECL circuit comprising a differential pair of transistors (TR1, TR2) a set transistor (TR3) and a set resistor (Rs) connected between the emitters of the differential pair of transistors (TR1, TR2) and the emitter of the set transistor (TR3); whereby the output of the ECL circuit can be fixed to a «high» level securely only by applying a «high» level signal having the same level as the «high» level signal of the data input to the base of the set transistor.
Patent IE-47028-B1 (IE)
Title: Process for the purification of mercaptobenzothiazole
IPC: C07D277/72
Filed: 1978-07-11
Abstract: Process for the purification of mercaptobenzothiazole prepared according to known processes, characterized in that the crude product is treated with carbon tetrachloride or with 1,1,2,2-tetrachloroethylene.
[US4192804A]
Patent IE-53018-B1 (IE)
Title: Compound sanitary napkin
IPC: A61F13/15
Filed: 1982-06-11
Abstract: Compound sanitary napkins comprising a primary men. strual pad and a panty protector joined by union means having limited extent. The primary menstrual pad comprises an absorbent core and, optionally, a pad overwrap and, also optionally, a fluid barrier. The panty protector comprises an absorbent element and a moisture barrier and, optionally, a protector overwrap and, also optionally, adhesive attachment means. The two constituents are joined at their corresponding ends, with the absorbent element of the panty protector interposed between the moisture barrier of the panty protector and the primary menstrual pad, by the union means in such a manner that the two are free to move relative to one another along essentially their entire common length. In use, the compound sanitary napkin is secured to the user's undergarments (as by the optional adhesive attachment means) in such a position that the primary menstrual pad is interposed between the panty protector and the user's body.
Patent IE-36798-B1 (IE)
Title: Improvements in or relating to cigarette filters
IPC: A24D3/08
Filed: 1971-11-12
Abstract: Cigarette filter contains an extruder element of foamed open celled resin (thermoplastic HD polyethylene or polypropylene) having the same section as the cigarette and a microstructure giving the filter a hardness coefficient >50% pressure loss 15g/cm2 and tar filtration yield >20%. Foam density is 0.015-0.1 g/cm3 and specific area is 10-80 m2/g. The microstructure contains gaps bridged by strands (0.1-2 microns) of fibre (about 100 per gap) forming a network. The resin is softened at 130-150 degrees C and expanded with 0.2 mole of foaming agent (lower hydrocarbon) per 100g product.
[FR2114696A5]
Patent IE-65629-B1 (IE)
Title: Process for the separation of 1,1,1,2-tetrafluoroethane from mixtures thereof with hydrogen fluoride and/or 1-chloro-2,2-difluoroethylene
Inventor: TAYLOR ANDREW MARK
IPC: B01D3/36
Filed: 1991-06-20
Abstract: A method for separating HFA 134a from an HFA 134a-rich mixture thereof with HF and/or CFC 1122 which comprises feeding the mixture to a distillation column to separate an azeotrope or near-azeotrope of HFA 134a and HF and/or CFC 1122 from a residue comprising substantially pure HFA 134a. Starting from an HF-rich mixture of HFA 134a such as a typical product stream in HFA 134a production, the method includes a first distillation step to separate HF from the initial mixture and produce an azeotrope or near azeotrope of HFA 134a and HF which is an HFA 134a-rich mixture.
Patent IE-58524-B1 (IE)
Title: Polypeptide derivatives containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
IPC: C07K1/00
Filed: 1986-08-08
Abstract: Polypeptide derivatives containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues are of the formula:wherein, for example in a preferred embodiment R is t-butyloxycarbonyl, m and n are each 0 or 1, their sum being at least 1; R is cyclohexylmethyl; R<sup>2</sup> is 2-methylpropyl, 2-methyl-2--propenyl, benzyl, 4-chlorobenzyl, 3-chlorobenzyl, 4-methylbenzyl, 4-methoxybenzyl, 3,4-dichlorobenzyl, 2-chlorobenzyl or cyclohexylmethyl; R<sup>3</sup> is hydrogen; R<sup>4</sup> is hydrogen, methyl, 4-aminobutyl, 2-carboxyethyl, 3-(ethoxycarbonyl)propyl or 3-(benzyloxycarbonyl)propyl; W is phenylalanyl, W<sup>1</sup> is histidyl and W<sup>2</sup> is lysyl.These compounds are useful for inhibiting the angiotensinogen cleaving action of the enzyme renin having particular utility in the treatment of hypertension.
Patent IE-42056-B1 (IE)
Title: Microsealed pharmaceutical delivery device
IPC: A61K9/52
Filed: 1975-10-23
Abstract: 1522846 Pharmaceutical sustained release device G D SEARLE & CO 23 Oct 1975 [24 Oct 1974] 43554/75 Heading ASB A pharmaceutical delivery device having sealed microscopic compartments comprises a biologically acceptable polymer container in the form of hollow tubing with as many perforations in the wall of the tubing when sealed at one or both ends or unsealed at both ends as to expose up to 40% of a biologically acceptable crosslinked silicone polymer matrix, said biologically acceptable crosslinked silicone polymer matrix having the formula: wherein R' is an alkoxy radical containing from 1 to 7 carbon atoms, an alkyl radical containing from 1 to 10 carbon atoms, phenyl, vinyl or allyl and m has a value of from 100 to 5000, said biologically acceptable silicone polymer matrix having sealed microscopic compartments with diameters of 10 to 200 microns, said sealed microscopic compartments containing a hydrophilic solvent system as herein defined saturated with a pharmaceutical, wherein the ratio of the partition coefficient of the pharmaceutical between the hydrophilic solvent system and the biologically acceptable silicone polymer matrix, to the solubility of the pharmaceutical in the hydrophilic solvent system is from 1 to 10-4 (ml/mcg), said pharmaceutical being diffusible through the biologically acceptable silicone polymer matrix and the biologically acceptable polymer container at a constant rate when the pharmaceutical delivery device is in an aqueous environment, said hydrophilic solvent system being non-diffusible through either the biologically acceptable silicone polymer matrix or the biologically acceptable polymer container.
Patent IE-42363-B1 (IE)
Title: New cyclic imides, processes for their preparation and medicaments containing these imides
IPC: C07C271/22
Filed: 1975-12-01
Abstract: The novel compounds correspond to the formula:  in which R represents the methyl, ethyl or n-propyl radical. They are prepared starting from beta -phthalimidoglutaric acid or one of its functional derivatives by reaction with an amine H2N-R or a salt thereof, or from a 4-aminopiperidine-2,6-dione substituted on N<1> by R or one of its salts by reaction with phthalic anhydride, phthaloyl chloride or an activated derivative of phthalimide. The compounds, in particular those in which R represents the n-propyl radical, are able to suppress the growth of tumours and have a very low toxicity.
Patent IE-62093-B1 (IE)
Title: Improved method and apparatus for coin sorting and counting
Inventor: MANTOVANI JOHN C
IPC: G07D5/08
Filed: 1989-08-15
Abstract: This is a coin sorting and counting apparatus for providing very accurate high throughput processing of heterogeneous coin mixtures. A rotating drum having parallel annular channels, each of which has equally spaced counterbores located around it is rotated within a vacuum plenum. A novel sensor coil constructed as a balanced transformer of four coils having rectangular geometries is used, in conjunction with a dual frequency excitation signal, to detect at least three electronic signatures for each coin, the signatures are detected by separating the frequency components in the output of the sensor coil and obtaining a peak value for the excursion of the high frequency response caused by passage of the coin, and width values corresponding to the time the excursion of the signal was above a predetermined threshold for both the high and low frequency responsive channels. Based on the denomination determined, appropriate signals are inserted into a coin ejection memory queue which is shifted in synchronism with rotation of the drum. The memory queue is constructed so that an appropriate air valve will be activated when the detected coin is over an appropriate one of a plurality of coin receiving stations. A set of lag sensors are used downstream from the coin ejecting air valves to confirm proper ejection of the coins. Separate calibration values for the signature signals are acquired and saved for each counterbore location to offset the effects of variations in circuitry on a channel-by-channel basis and slight mechanical irregularities in movement of the counterbores past the sensor array.
Patent IE-61663-B1 (IE)
Title: Improved metal complex-containing pharmaceutical agents
Inventor: GRIES HEINZ DR
IPC: A61K47/48
Filed: 1987-11-27
Abstract: The pharmaceuticals contain as additive one or more complexing agent(s) and/or one or more weak metal complex(es) or mixtures thereof.
Patent IE-57150-B1 (IE)
Title: A method and an apparatus for processing whey and/or permeate from a cheese-working process
IPC: A23C1/00
Filed: 1985-12-31
Abstract: A method of and an apparatus for converting liquid whey or permeate from a cheese-making process (20) to a non-caking powder comprising vacuum evaporating the liquid whey including using a finishing evaporator (44), until the whey is about 75% solid, the lactose which is converted into its alpha-monohydrate form by a cooled heat exchanger (50), after which a spin flash dryer (60) having a hot air fluidized bed converts the whey into a non-caking powder.
Patent IE-62863-B1 (IE)
Title: Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
Inventor: KRANTZ ALEXANDER
IPC: C07C239/00
Filed: 1987-12-21
Abstract: Thiol protease inhibitors are disclosed having the formula: or an optical isomer thereof, or a pharmaceutically acceptable salt thereof, wherein: n is 0 or 1; m is 0, 1 or 2; X is H or an N-protecting group; each Y is independently an optionally protected alpha -amino acid residue; R is an optionally protected alpha -amino acid side chain that is H or CH3 or that is bonded to the alpha -carbon atom to which it is attached by a methylene, methine or phenyl radical; and R' is optionally substituted aryl.
Patent NO-302763-B1 (NO)
Inventor: CANE CHARLES
IPC: C10M159/22
Filed: 1988-07-28
Abstract: An additive concentrate suitable for incorporation into a finished lubricating oil composition, the additive concentrate comprising:  (a) a lubricating oil, (b) a lubricating oil soluble sulphurised alkaline earth metal hydrocarbyl phenate modified by incorporation of from greater than 2 to 35% by weight based on the weight of the composition of either (i) at least one carboxylic acid having the formula:-            R - @@ - COOH      (I)   wherein R is a C10 to C24 alkyl or alkenyl group and R<1> is either hydrogen, as C1 to C4 alkyl group or a -CH2-COOH group, or an anhydride, acid chloride or ester thereof or (ii) a di- or polycarboxylic acid containing from 36 to 100 carbon atoms or an anhydride, acid chloride or ester thereof, the composition having a TBN greater than 300.
Patent NO-302217-B1 (NO)
Inventor: ANDERSSON JAN
IPC: A61L2/20
Filed: 1990-11-05
Abstract: A method of producing a gaseous, hydrogen peroxide-containing sterilisation fluid displaying good, uniform sterilisation properties, by vaporisation of liqueform hydrogen peroxide which is injected intermittently in finely-divided form into an air current serving as vaporisation agent which is kept at a constant or but insignificantly varying elevated vaporisation temperature. The even vaporisation temperature of the air current is ensured in that the air, prior to the vaporisation, is heated by heat exchange with a heating element (11) of large mass (thermal capacity) and large heat exchange surface area which is kept at the de- sired elevated temperature by regulated energy supply to the heating element and which, during breaks in vaporisation between the intermittent injection of the liqueform hydrogen peroxide, is heated with the aid of heat stored in the heating element.
Patent NO-304352-B1 (NO)
Inventor: ALMUN TORSTEN
IPC: A61K47/02
Filed: 1992-09-08
Abstract: A contrast medium of aq. carrier, dissolved contrast agent and dissolved sodium cpd. providing a sodium ion concn. of 15-75 mM Na/l is characterised in that it also contains a dissolved calcium salt and opt. potassium and magnesium salts in a total concn. of up to 0.8 mM Ca/l and up to 2 mM K/l, the ratio of sodium ions to calcium ions being greater than 55. Pref. the Ca concn. is 0.05-0.7 mM Ca(2+)/l (esp. 0.1-0.6 mM Ca(2+)/l), the K concn. is 0.2-1.5 mM K(+)/l (esp. 0.3-1.2 mM K(+)/l) and the Mg concn. is up to 0.8 mM Mg(2+)/l (esp. 0.05-0.4 mM Mg(2+)/l). Pref. the contrast agent is iodinated e.g. iohexol, ioversol, iopamidol, iotrolan, ioxaglate or iodix anol.
Patent NO-301061-B1 (NO)
Title: Isolasjonsbånd og fremgangsmåte ved dets fremstilling
Inventor: SCHULER ROLAND
IPC: B32B27/04
Filed: 1993-12-27
Abstract: Til forbedring av den termiske ledningsevne i hovedisolasjonen i en ledningsstav i en elektrisk maskin foreslås et isolasjonsbånd som består av et eller flere glassvevs- (6) og glimmerskikt (5). Hovedsakelig bare maskene i den av glasstråder (7) oppbygde glassvevnad (6) er fylt med harpiks (8) som er tilsatt et fyllstoff som inneholder mikroskopisk små partikler (9) med en ledningsevne som er større enn harpiksens. Som beskyttelse for vevnadens glasstråder (7) er disse tråder (7) forsynt med et beskyttelsesovertrekk (10) av harpiks eller lakk, hvorved dette beskyttelsesovertrekk (10) hovedsakelig bare omgir trådene i glassvevnaden (6) og forøvrig ikke utfyller maskene i vevnaden.En hovedisolasjon som er oppbygd av et slikt isolasjonsbånd, oppfyller alle krav med hensyn til mekanisk og termisk bestandighet og elektrisk fasthet.
Patent NO-313785-B1 (NO)
Inventor: SNELL DOROTHY JILL
IPC: A61K31/56
Filed: 1996-11-20
Abstract: PCT No. PCT/EP95/01913 Sec. 371 Date Feb. 7, 1997 Sec. 102(e) Date Feb. 7, 1997 PCT Filed May 19, 1995 PCT Pub. No. WO95/31964 PCT Pub. Date Nov. 30, 1995Suspension formulations suitable for nebulization, for administration by inhalation, comprising fluticasone propionate with a particle size less than 12 microns, one or more surfactants, one or more buffer agents and water. Also described are a method of preparing such a formulation, a container comprising the formulation, and a method of treating asthma using the formulation.
Patent NO-326192-B1 (NO)
Inventor: ALAMI MOUAD
IPC: C07D257/04
Filed: 1999-03-19
Abstract: The subject-matter of the invention is a process for the preparation of substituted 4-methylbiphenyls of general formula:in which R is a cyano group or a protected tetrazolyl group of formula:in which R1, situated at the 1 or 2 position of the tetrazolyl group, is a protective group, characterized in that a halobenzene of formula:in which Hal is a halogen atom and R has the same meaning as above, is reacted with a p-tolylmagnesium halide in the presence of a linear or branched polyether and of a catalyst comprising a transition metal.
Patent AT-520919-B1 (AT)
Title: Transportbehälter zum Transport von temperaturempfindlichem Transportgut
IPC: F25D3/08
Filed: 2018-05-29
Granted: 2019-09-15
Abstract: Bei einem Transportbehälter zum Transport von temperaturempfindlichem Transportgut, umfassend eine Kammer (2) zur Aufnahme des Transportguts und eine die Kammer (2) umschließende Hülle (1), wobei die Hülle (1) wenigstens ein erstes Latentwärmespeicherelement (7) umfasst, das mit der Kammer (2) in Wärmeaustauschverbindung steht und das ein bei Gebrauchstemperatur formstabiles Trägermaterial und ein in der Masse des Trägermaterials verteiltes Phasenwechselmaterial umfasst, sodass das wenigstens eine erste Latentwärmespeicherelement (7) in einem Temperaturbereich sowohl unterhalb als auch oberhalb des Schmelzpunktes des Phasenwechselmaterials formstabil ist, ist vorgesehen, dass das wenigstens eine erste Latentwärmespeicherelement (7) als die Kammer (2) im Querschnitt gesehen wenigstens über den halben Umfang einteilig umgebendes Gussteil ausgebildet ist.
Patent AT-512963-B1 (AT)
Title: Programmiervorlage für verteilte Anwendungsprogramme
Inventor: SCHULTZE STEPHAN
IPC: G05B19/05
Filed: 2013-05-27
Granted: 2015-10-15
Abstract: Die Erfindung betrifft eine Programmiervorlage (20A, 21A, 22A, 30A) für die Entwicklung eines auf zwei oder mehr speicherprogrammierbaren Steuerungen (10,11,12) verteilt auszuführenden Anwendungsprogramms (20B, 21B, 22B). Die Programmiervorlage umfasst zwei oder mehr programmierbare Module (201A, 221A, 313A, 314A, 323A, 324A), die in das Anwendungsprogramm integriert und auf einer jeweils zugeordneten speicherprogrammierbaren Steuerung (10,11,12) ausgeführt werden können. Mindestens ein erstes der programmierbaren Module (313A, 314A) ist einer ersten (10) und mindestens ein zweites der programmierbaren Module (323A, 324A) ist einer zweiten (11) der speicherprogrammierbaren Steuerungen zugeordnet ist. Zu einer Steuerungsübergreifenden Koordination des mindestens einen ersten und des mindestens einen zweiten programmierbaren Moduls umfasst die Programmiervorlage eine logische Kommunikationsverbindung (33) zwischen dem mindestens einen ersten und dem mindestens einen zweiten programmierbaren Modul.
Patent AT-503399-B1 (AT)
Inventor: OSWALD BERNHARD
IPC: B60P7/08
Filed: 2006-03-29
Granted: 2008-12-15
Abstract: The device has an attachment part (ANS) rotatably supported in a retainer opening, which is formed through a connecting part (VER). A clamping spring (KLE) is provided for the attachment part. The connecting part has an outside open cavity (MUL) for the clamping spring, where the cavity is remote from the retainer opening. The clamping spring contacts the attachment part only in the region area, which is turned toward a fixing part (BEF).
Patent AT-511469-B1 (AT)
Title: Vorrichtung zum reinigen der aussenfläche von wärmetauschern
Inventor: RAINER JOHANNES
IPC: F28G1/10
Filed: 2011-06-07
Granted: 2012-12-15
Abstract: Eine Vorrichtung zum Reinigen der Außenfläche (2) von Wärmetauschern (1) umfasst eine längs einer Erzeugenden des Wärmetauschers (1) vorgesehene Zahnstange (4), auf der ein Mitnehmer (8) mit einem Antriebsmotor (6) und einem in die Zahnstange (4) eingreifenden Zahnrad (5) fährt. Es kann auch eine Gewindespindel (22) mit ortsfestem Antriebsmotor (23) zum Verfahren eines Mitnehmers (24) vorgesehen sein. Mit dem Mitnehmer (8, 24) ist ein zweigeteilter Abstreifer (9, 25) mit gegen die Außenfläche (2) des Wärmetauschers (1) gerichteten federnden Schabern (12) verbunden, der die Außenfläche (2) backenartig umgreift. Das freie Ende kann in Führungsnuten (18, 19) eines Sockels (3) bei liegender Anordnung des Wärmetauschers (1) mittels Gleitstücken (20, 21) verschiebbar, jedoch gegen seitliches Auslenken gesichert sein. Ein auf dem Mitnehmer (8) mitfahrender Druckluft- oder Druckwassermotor (7) kann die Druckluft oder das Druckwasser über den Abstreifer (9) mittels Düsen (17) gegen die Außenfläche (2) ausblasen.
Patent AT-506895-B1 (AT)
Title: Verfahren zur würzebehandlung während der heisstrubabscheidung sowie vorrichtung zur heisstrubabscheidung
Inventor: HERTEL MARCUS DR ING
IPC: C12C7/24
Filed: 2008-05-28
Granted: 2012-04-15
Abstract: Es werden ein Verfahren und eine Vorrichtung zur Würzebehandlung während der Heißtrubabscheidung im Brauprozess angegeben. Hierbei ist es vorgesehen, die noch heiße Würze (6) nach dem Würzekochen zur Heißtrubabscheidung (1) einem Abscheidebehälter (2) zuzuleiten. Mittels einer entsprechend ausgestalteten Einrichtung wird der Druck im Behälter kontinuierlich und langsam reduziert. Infolge dieser Druckreduzierung kommt es zu einem zumindest teilweisen Sieden der im Behälter befindlichen Würze, wodurch eine effiziente Austreibung von leichtflüchtigen, unerwünschten Aromastoffen hervorgerufen wird.
Patent BR-PI0006634-B1 (BR)
Inventor: CALLAGHAN THERESA
IPC: A61K36/28
Filed: 2000-06-02
Abstract: This invention relates to a method of treating and preventing inflammatory disorders and related conditions using an extract of feverfew. Particularly, the invention includes a method of treating and preventing inflammatory disorders and related conditions which comprises applying a topical composition comprising an effective amount of an extract of feverfew to a patient and a method of treating and preventing inflammatory disorders and related conditions of the skin by applying a topical composition containing an effective amount of an extract of feverfew to a patient. In addition, the invention includes a method of treating and preventing inflammatory disorders and related conditions by applying a topical composition containing an effective amount of an extract of feverfew to a patient where said extract is substantially free of alpha-unsaturated gamma-lactone.
Patent BR-0111677-B1 (BR)
Inventor: HOEHE KURT
IPC: F16J15/08
Filed: 2001-06-15
Abstract: The invention relates to a flat gasket, having at least one metallic layer in which at least one port is formed, the metallic layer or at least one of the metallic layers (1) being formed at least in regions in the form of an undulating and/or serrated profiling (2) around the port(s).